These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32622856)

  • 1. FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention.
    Annett S; Moore G; Robson T
    Pharmacol Ther; 2020 Nov; 215():107623. PubMed ID: 32622856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 binding proteins as targets in anticancer therapy.
    Romano S; Di Pace A; Sorrentino A; Bisogni R; Sivero L; Romano MF
    Anticancer Agents Med Chem; 2010 Nov; 10(9):651-6. PubMed ID: 21182472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of FKBP family protein: evaluation, structure, and function in mammals and Drosophila melanogaster.
    Ghartey-Kwansah G; Li Z; Feng R; Wang L; Zhou X; Chen FZ; Xu MM; Jones O; Mu Y; Chen S; Bryant J; Isaacs WB; Ma J; Xu X
    BMC Dev Biol; 2018 Mar; 18(1):7. PubMed ID: 29587629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506-Binding Proteins and Their Diverse Functions.
    Tong M; Jiang Y
    Curr Mol Pharmacol; 2015; 9(1):48-65. PubMed ID: 25986568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
    Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
    Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FKBP52.
    Davies TH; Sánchez ER
    Int J Biochem Cell Biol; 2005 Jan; 37(1):42-7. PubMed ID: 15381148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large FK506-binding proteins shape the pharmacology of rapamycin.
    März AM; Fabian AK; Kozany C; Bracher A; Hausch F
    Mol Cell Biol; 2013 Apr; 33(7):1357-67. PubMed ID: 23358420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium- and FK506-independent interaction between the immunophilin FKBP51 and calcineurin.
    Li TK; Baksh S; Cristillo AD; Bierer BE
    J Cell Biochem; 2002; 84(3):460-71. PubMed ID: 11813252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP immunophilins and Alzheimer's disease: a chaperoned affair.
    Cao W; Konsolaki M
    J Biosci; 2011 Aug; 36(3):493-8. PubMed ID: 21799260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBPs and the Akt/mTOR pathway.
    Hausch F; Kozany C; Theodoropoulou M; Fabian AK
    Cell Cycle; 2013 Aug; 12(15):2366-70. PubMed ID: 23839048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Plasmodium falciparum FK506-binding protein (FKBP) with peptidyl-prolyl cis-trans isomerase and chaperone activities.
    Monaghan P; Bell A
    Mol Biochem Parasitol; 2005 Feb; 139(2):185-95. PubMed ID: 15664653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506.
    Davies TH; Ning YM; Sánchez ER
    Biochemistry; 2005 Feb; 44(6):2030-8. PubMed ID: 15697228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
    Bierer BE; Mattila PS; Standaert RF; Herzenberg LA; Burakoff SJ; Crabtree G; Schreiber SL
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9231-5. PubMed ID: 2123553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity.
    Kumar R; Adams B; Musiyenko A; Shulyayeva O; Barik S
    Mol Biochem Parasitol; 2005 Jun; 141(2):163-73. PubMed ID: 15850699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into
    Rajan S; Yoon HS
    Front Cell Infect Microbiol; 2022; 12():931635. PubMed ID: 36118020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury.
    Lagoda G; Sezen SF; Burnett AL
    J Sex Med; 2009 Jul; 6(7):1914-23. PubMed ID: 19453873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.
    Xu X; Su B; Barndt RJ; Chen H; Xin H; Yan G; Chen L; Cheng D; Heitman J; Zhuang Y; Fleischer S; Shou W
    Transplantation; 2002 Jun; 73(11):1835-8. PubMed ID: 12085010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of FKBP associated protein 48 (FAP48) at proline 219 disrupts the interaction with FKBP12 and FKBP52.
    Neye H
    Regul Pept; 2001 Mar; 97(2-3):147-52. PubMed ID: 11164950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.